It has been proved that NAFLD progression is accompanied by gut barrier dysfunction (18), so we detected expressions of tight junction proteins ZO-1, Occludin, and mucus layer component MUC2 in the ileum and found impaired gut barrier function as NAFLD progressed (Fig. S1A and B). This evidence concerns the gene OCLN and metabolic dysfunction-associated steatotic liver disease.